Merck opens new USD550 research facility in Pennsylvania

15. Oct 2026

(AWP Alliance News) - Merck & Co Inc - Rahway, New Jersey-based pharmaceutical company - inaugurates a USD550 million research facility on West Point campus, Pennsylvania. The new site called Advance aims at simplifying the analysis of biological samples from Merck's ongoing clinical trials through the use of artificial intelligence and robotics. "The life sciences industry is booming in Pennsylvania and I am committed to winning more investments like this and making sure our Commonwealth remains a national leader in innovation, medicine and manufacturing," says Pennsylvania Governor Josh Shapiro, present at the ribbon-cutting ceremony. Merck Chair & Chief Executive Officer Rob Davis says: "The Advance facility represents the future of clinical development at Merck and underscores our continued commitment to addressing the needs of the patients we serve."

Current stock price: up 0.8% to USD148.50 in premarket trading in New York

12-month change: up 75%

By Camilla Borri, Alliance News reporter

Comments and questions to newsroom [at] alliancenews.com